U.S. Markets close in 2 hrs 24 mins

ReWalk Robotics Ltd. (RWLK)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
1.2701-0.0099 (-0.77%)
As of 1:34PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close1.2800
Open1.3000
Bid1.2700 x 800
Ask1.2800 x 900
Day's Range1.2700 - 1.3150
52 Week Range0.4100 - 3.9000
Volume231,414
Avg. Volume1,054,734
Market Cap24.308M
Beta (5Y Monthly)3.78
PE Ratio (TTM)N/A
EPS (TTM)-2.0370
Earnings DateAug 06, 2020 - Aug 10, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.50
  • Centers for Medicare & Medicaid Services Issues Code for ReWalk Personal Exoskeleton
    PR Newswire

    Centers for Medicare & Medicaid Services Issues Code for ReWalk Personal Exoskeleton

    ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a manufacturer of robotic medical devices for individuals with lower limb disabilities, today announced the Centers for Medicare and Medicaid Services ("CMS") issued Healthcare Common Procedure Coding System ("HCPCS") Level II Code K1007 in response to the Company's application. This decision, which will be effective on October 1, 2020, establishes the first such code for exoskeletons.

  • GlobeNewswire

    ReWalk Robotics Announces Closing of $9.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

    ReWalk also issued unregistered warrants to purchase up to an aggregate amount of 2,469,139 ordinary shares. The warrants have a term of five and one-half years, are exercisable immediately following the issuance date and have an exercise price of $1.76 per ordinary share.

  • GlobeNewswire

    ReWalk Robotics Announces $9.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

    ReWalk has also agreed to issue to the investors unregistered warrants to purchase up to an aggregate amount of 2,469,139 ordinary shares. The warrants will have a term of five and one-half years, be exercisable immediately following the issuance date and have an exercise price of $1.76 per ordinary share. The Company intends to use the net proceeds from the offering for the following purposes: (i) sales, marketing and reimbursement expenses related to market development activities of the Company’s ReStore device, broadening third-party payor coverage for the ReWalk Personal device and commercializing its new product lines added through distribution agreements; (ii) research and development costs related to the Company’s products maintenance, as well as developing its lightweight exo-suit technology for potential home rehab with tele-heath features.